Search

everythinglearnresearchcommunity

for

Search:↓

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Spironolactone effectively reduces unwanted hair growth in women with hirsutism.

Bicalutamide improved hair growth more than spironolactone in women with hair loss.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

ChuZhiShengFaPian and Licorzine Granules effectively treat early male hair loss.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

A new method accurately measures clobetasol propionate in hair and skin.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The 2% spironolactone cream did not reduce hair growth in women with facial hirsutism.

Oral clindamycin and rifampicin are the most effective treatments for Folliculitis decalvans.

Nanostructured lipid carriers can effectively deliver spironolactone to hair follicles for treating hair loss.

The hair treatment made hair grow faster and thicker and strengthened the hair roots.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.